Connecting you to content on EBSCOhost

Works by Munster, P. N.

Results: 4

1

Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma.

Published in:

British Journal of Cancer, 2012, v. 106, n. 1, p. 85, doi. 10.1038/bjc.2011.514

By:

Algazi, A P;
Weber, J S;
Andrews, S C;
Urbas, P;
Munster, P N;
DeConti, R C;
Hwang, J;
Sondak, V K;
Messina, J L;
McCalmont, T;
Daud, A I

Publication type:

Article

2

A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer.

Published in:

2011

By:

Munster, P. N.;
Thurn, K. T.;
Thomas, S.;
Raha, P.;
Lacevic, M.;
Miller, A.;
Melisko, M.;
Ismail-Khan, R.;
Rugo, H.;
Moasser, M.;
Minton, S. E.

Publication type:

journal article

3

Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker.

Published in:

2009

By:

Munster, P. N.;
Marchion, D.;
Thomas, S.;
Egorin, M.;
Minton, S.;
Springett, G.;
Lee, J.-H.;
Simon, G.;
Chiappori, A.;
Sullivan, D.;
Daud, A.

Publication type:

journal article

4

PI-13.

Published in:

Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 2, p. P10, doi. 10.1016/j.clpt.2005.12.034

By:

Guo, F.;
Letrent, S. P.;
Noe, D. A.;
Qin, A.;
Rohrbacher, K. D.;
Munster, P. N.;
Tolcher, A. W.;
Britten, C. D.;
Gelmon, K.;
Sharma, A.

Publication type:

Article